These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2938736)

  • 41. Effector cell analysis of tumor cell rejection in vivo in two syngeneic tumor systems exhibiting distinct in vitro cytotoxic mechanisms.
    Fukuzawa M; Fujiwara H; Yoshioka T; Itoh K; Hamaoka T
    Gan; 1984 Oct; 75(10):912-9. PubMed ID: 6334626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
    Lake JP; Kapp JA; Pierce CW
    J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the recovery from tolerance to tumor antigens. I. Bone marrow cells from tolerant hosts are not rendered tolerant, but provide potential to reconstitute tumor-specific effector T cell clones.
    Fujiwara H; Sato S; Kosugi A; Fukuzawa M; Hamaoka T
    Cancer Immunol Immunother; 1987; 24(2):113-20. PubMed ID: 3493844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of helper T cells on prevention of tolerance induction in effector T cells responsible for syngeneic tumor immunity.
    Fujiwara H; Kinouchi T; Tsuchida T; Aoki H; Hamaoka T
    Gan; 1982 Oct; 73(5):766-72. PubMed ID: 6219908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
    Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
    J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection.
    Larsen HS; Feng MF; Horohov DW; Moore RN; Rouse BT
    J Virol; 1984 Apr; 50(1):56-9. PubMed ID: 6608007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.
    Sugihara S; Izumi Y; Yoshioka T; Yagi H; Tsujimura T; Tarutani O; Kohno Y; Murakami S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Jul; 141(1):105-13. PubMed ID: 2967864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.
    Mielke ME; Ehlers S; Hahn H
    Infect Immun; 1988 Aug; 56(8):1920-5. PubMed ID: 2969373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. II. Establishment of tumor-specific immunotherapy models utilizing MDP hapten-reactive helper T cell activity.
    Sano H; Kosugi A; Sano S; Fujiwara H; Hamaoka T
    Cancer Immunol Immunother; 1987; 25(3):180-4. PubMed ID: 2960447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
    Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
    Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfer of protection to murine typhoid conferred by L-form Salmonella typhimurium in dependence of cooperation between L form-adopted macrophages and L form-induced Lyt-2+ T cells.
    Nishikawa F; Kita E; Matsui N; Kashiba S
    Microbiol Immunol; 1994; 38(3):201-7. PubMed ID: 8078425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.